Gradient Investments’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
RCM
SCM
RJA
AC
AW
Gradient Investments's BCAT Position: Q4 2022 in Review
Gradient Investments sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q4 2022, closing a stake of 1,121 shares — an estimated $15K sold.
Gradient Investments first reported a position in BCAT in Q3 2022 and held it in 1 quarter. The position peaked at $15K in Q3 2022. 85 funds tracked by Wall St. Rank hold BCAT as of Q4 2022.
- Gradient Investments reported no remaining BlackRock Capital Allocation Term Trust position as of Q4 2022 after selling out during the quarter.
- Gradient Investments sold 1,121 BlackRock Capital Allocation Term Trust shares in Q4 2022, an estimated $15K.
- Gradient Investments first reported a position in BlackRock Capital Allocation Term Trust in Q3 2022 and held it in 1 quarter.
- Gradient Investments's BlackRock Capital Allocation Term Trust position peaked at $15K in Q3 2022.
- 85 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q4 2022.
Based on Gradient Investments's 13F filing for Q4 2022, filed 10 Jan 2023.